← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$8K

Shares

3,250

Price

$2

Filed

May 29

Insider

Name

Hohl Benjamin

Title

CHIEF FINANCIAL OFFICER

CIK

0001882764

Roles

Officer

Transaction Details

Transaction Date

2025-05-27

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

26,250

Footnotes

The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. | This transaction was executed in multiple trades at prices ranging from $15.925 to $16.675. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Filing Info

Accession No.

0001415889-25-014913

Form Type

4

Issuer CIK

0001672619

Hohl Benjamin's History

Date Ticker Type Value
2026-03-06 ELVN $296K
2026-02-12 ELVN A $0
2026-02-12 ELVN A $0
2025-12-22 ELVN M $32K
2025-12-22 ELVN M $0
2025-09-29 ELVN M $8K
2025-09-29 ELVN $66K
2025-09-29 ELVN M $0
2025-08-27 ELVN M $8K
2025-08-27 ELVN $67K

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12